fr-264205 and Lung-Abscess

fr-264205 has been researched along with Lung-Abscess* in 1 studies

Other Studies

1 other study(ies) available for fr-264205 and Lung-Abscess

Article	Year
Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat a carbapenem-resistant Pseudomonas Aeruginosa lung abscess on an outpatient antimicrobial program. International journal of antimicrobial agents, 2018, Volume: 51, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Humans; Infusions, Parenteral; Lung Abscess; Male; Microbial Sensitivity Tests; Middle Aged; Outpatients; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2018

Article

Year

Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat a carbapenem-resistant Pseudomonas Aeruginosa lung abscess on an outpatient antimicrobial program.

International journal of antimicrobial agents, 2018, Volume: 51, Issue:6

Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Humans; Infusions, Parenteral; Lung Abscess; Male; Microbial Sensitivity Tests; Middle Aged; Outpatients; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2018